Cite

HARVARD Citation

    Wan, W. et al. (2022). Preclinical anti‐angiogenic and anti‐cancer activities of BAY1143269 in glioblastoma via targeting oncogenic protein expression. Pharmacology research & perspectives. 10 (4), p. n/a. [Online]. 
  
Back to record